Jean-Jacques Bienaimé – Biography

Jean-Jacques was Director at Portola Pharmaceuticals, and Chairman and Chief Executive Officer at Genencor. Jean-Jacques Bienaimé joined Incyte in 2024. Jean-Jacques served as Director at Incyte.

Jean-Jacques Bienaimé is currently

• Chair, Nominating and Corporate Governance Committee at Keros Therapeutics - View - Keros Therapeutics org chart

• Director at Alpha-9 Oncology - View - Alpha-9 Oncology org chart

• Director at Immunome - View - Immunome org chart

• Director at Incyte - View - Incyte org chart

Create your alert
to follow the career of Jean-Jacques Bienaimé.

Jean-Jacques Bienaimé has a Diploma in Conometircs & Finance from École Supérieure de Commerce de Paris and a Master of Business Administration in Finance from University of Pennsylvania - The Wharton School.

They have also studied at École Supérieure de Commerce de Paris :

• Nathalie Pivet - EDF

• Claire Pedini - Saint-Gobain

• Emmanuel Touzeau - Axa

Find more alumni from École Supérieure de Commerce de Paris

They have also studied at University of Pennsylvania - The Wharton School :

• Dean Athanasia - Bank of America
• Ashley Alexander - OpenAI
• Sundar Pichai - Google

Find more alumni from University of Pennsylvania - The Wharton School

Here are a few tips for establishing great contacts.